BB-101 for Treatment of Diabetic Lower Leg and Foot Ulcers
NCT03888053
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
14
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetic Foot Ulcer
Interventions
BIOLOGICAL:
BB-101
Sponsor
Blue Blood Biotech Corp.